Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 4/20 | 0.38 |
| ▸ | ACHE | P22303 | 8/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.34 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.34 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.34 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.34 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2152670 | 0.94 | EPHX1 (0.42) | EPHX1MGLLTSHR | |
| SCHEMBL1937986 | 0.92 | EPHX1 (0.45) | EPHX1MGLL | |
| SCHEMBL1937316 | 0.92 | EPHX1 (0.45) | EPHX1MGLL | |
| SCHEMBL11125409 | 0.92 | EPHX1 (0.45) | EPHX1MGLL | |
| SCHEMBL11726259 | 0.92 | EPHX1 (0.45) | EPHX1MGLL | |
| SCHEMBL12669343 | 0.92 | EPHX1 (0.45) | EPHX1MGLL | |
| SCHEMBL1937657 | 0.92 | EPHX1 (0.45) | EPHX1MGLL | |
| SCHEMBL11810751 | 0.92 | EPHX1 (0.45) | EPHX1MGLL | |
| SCHEMBL2152762 | 0.92 | EPHX1 (0.45) | EPHX1MGLL | |
| SCHEMBL918587 | 0.92 | EPHX1 (0.45) | EPHX1MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250235390-A1 | Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-07-24 | — | — | US | disclosed |
| EP-3534867-B1 | MEDICAL COMPOSITION CONTAINING GUANIDINYL-CONTAINING POLYMER(S) AND CARRAGEENANE(S) | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-06-04 | — | — | EP | disclosed |
| EP-3534866-B1 | METHOD OF DENTAL RETRACTION WITH COMPOSITION WITH GUANIDINYL-CONTAINING POLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-05-28 | — | — | EP | disclosed |
| US-12295369-B2 | Articles containing a crosslinked guanidinyl-containing polymer and uses thereof | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-05-13 | — | — | US | disclosed |
| US-20250082440-A1 | Composition for Isolating Tissue | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-03-13 | — | — | US | disclosed |
| EP-4419062-A1 | COMPOSITION AND PROCESS FOR TREATING A DISORDER IN THE ORAL CAVITY OF A MAMMAL | Solventum Intellectual Properties Company (US) | 2024-08-28 | — | — | EP | disclosed |
| CN-114173560-B | Articles comprising crosslinked guanidine-containing polymers and uses thereof | 舒万诺知识产权公司 | 2024-07-09 | — | — | CN | disclosed |
| EP-4380494-A1 | COMPOSITION FOR ISOLATING TISSUE | Solventum Intellectual Properties Company (US) | 2024-06-12 | — | — | EP | disclosed |
| US-20240024205-A1 | DENTAL RETRACTION COMPOSITION | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-01-25 | — | — | US | disclosed |
| US-11827864-B2 | Wipe with a guanidinyl-containing polymer | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-11-28 | — | — | US | disclosed |
| EP-1913070-B1 | STABILISER COMPOSITIONS BASED ON NITROGEN COMPOUNDS FOR STABILISING HALOGENATED POLYMERS | BAERLOCHER GMBH (DE) | 2011-07-06 | — | — | EP | disclosed |
| US-20090048374-A1 | STABILIZER COMPOSITIONS FOR HALOGENATED POLYMERS WITH IMPROVED INITIAL COLOR AND IMPROVED COLOR MAINTENANCE | BAERLOCHER GMBH (DE) | 2009-02-19 | — | — | US | disclosed |
| EP-1996649-A1 | STABILIZER COMPOSITIONS FOR HALOGENATED POLYMERS WITH IMPROVED INITIAL COLOR AND IMPROVED COLOR MAINTENANCE | Baerlocher GmbH (DE) | 2008-12-03 | — | — | EP | disclosed |
| EP-1913067-A1 | STABILIZER COMPOSITIONS BASED ON GUANIDINE OR MELAMINE COMPOUNDS TO STABILIZE HALOGEN-CONTAINING POLYMERS | Baerlocher GmbH (DE) | 2008-04-23 | — | — | EP | disclosed |
| EP-1913070-A2 | STABILISER COMPOSITIONS BASED ON NITROGEN COMPOUNDS FOR STABILISING HALOGENATED POLYMERS | Baerlocher GmbH (DE) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007104379-A1 | STABILIZER COMPOSITIONS FOR HALOGENATED POLYMERS WITH IMPROVED INITIAL COLOR AND IMPROVED COLOR MAINTENANCE | BAERLOCHER GMBH (DE) | 2007-09-20 | — | — | WO | disclosed |
| WO-2007019999-A1 | STABILIZER COMPOSITIONS BASED ON GUANIDINE OR MELAMINE COMPOUNDS TO STABILIZE HALOGEN-CONTAINING POLYMERS | BAERLOCHER GMBH (DE) | 2007-02-22 | — | — | WO | disclosed |
| WO-2007020000-A2 | STABILISER COMPOSITIONS BASED ON NITROGEN COMPOUNDS FOR STABILISING HALOGENATED POLYMERS | BAERLOCHER GMBH (DE) | 2007-02-22 | — | — | WO | disclosed |
| US-4670592-A | BACTERICIDES, FUNGICIDES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-06-02 | — | — | US | disclosed |
| EP-0125092-A1 | Bisbiguanide compounds | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12295369-B2 | Articles containing a crosslinked guanidinyl-containing polymer and uses thereof | C5, YTHDC1, PRMT1 | EPHX1 1306/4885ACHE 2078/4885MMP2 2019/4885 |
| US-20240024205-A1 | DENTAL RETRACTION COMPOSITION | GK, GANC, JMJD1C | EPHX1 4493/4885ACHE 1647/4885MMP2 1063/4885 |
| US-20250235390-A1 | Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal | GSDMD, PIGS, GANC | EPHX1 961/4885ACHE 826/4885MMP2 160/4885 |
| US-11827864-B2 | Wipe with a guanidinyl-containing polymer | GNPDA1, GDA, PGLS | EPHX1 2349/4885ACHE 2050/4885MMP2 1123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.